Invention Grant
- Patent Title: Piperidine derivatives
- Patent Title (中): 哌啶衍生物
-
Application No.: US11996133Application Date: 2006-07-19
-
Publication No.: US08314127B2Publication Date: 2012-11-20
- Inventor: Talbir Austin , David O'Sullivan , Matthew Perry , Brian Springthorpe
- Applicant: Talbir Austin , David O'Sullivan , Matthew Perry , Brian Springthorpe
- Applicant Address: SE Sodertalje
- Assignee: Astrazeneca AB
- Current Assignee: Astrazeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Astrazeneca AB
- Priority: SE0501719 20050721; SE0600838 20060413
- International Application: PCT/SE2006/000893 WO 20060719
- International Announcement: WO2007/011293 WO 20070125
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; C07D211/46
Abstract:
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
Public/Granted literature
- US20080207688A1 Novel Piperidine Derivatives Public/Granted day:2008-08-28
Information query
IPC分类:
